173 related articles for article (PubMed ID: 15146346)
1. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors.
Blümcke I; Müller S; Buslei R; Riederer BM; Wiestler OD
Acta Neuropathol; 2004 Aug; 108(2):89-96. PubMed ID: 15146346
[TBL] [Abstract][Full Text] [Related]
2. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells.
Blümcke I; Becker AJ; Normann S; Hans V; Riederer BM; Krajewski S; Wiestler OD; Reifenberger G
J Neuropathol Exp Neurol; 2001 Oct; 60(10):984-93. PubMed ID: 11589429
[TBL] [Abstract][Full Text] [Related]
3. CD34 and microtubule-associated protein 2 expression in dysembryoplastic neuroepithelial tumours with an emphasis on dual expression in non-specific types.
Sung CO; Suh YL; Hong SC
Histopathology; 2011 Aug; 59(2):308-17. PubMed ID: 21884210
[TBL] [Abstract][Full Text] [Related]
4. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
5. Differential localization of high- and low-molecular-weight variants of microtubule-associated protein 2 in the developing rat telencephalon.
Fujimori K; Takauji R; Tamamaki N
J Comp Neurol; 2002 Aug; 449(4):330-42. PubMed ID: 12115669
[TBL] [Abstract][Full Text] [Related]
6. MAP2 and nestin co-expression in dysembryoplastic neuroepithelial tumors.
Duggal N; Iskander S; Hammond RR
Clin Neuropathol; 2003; 22(2):57-65. PubMed ID: 12670051
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characterization of canine neuroepithelial tumors.
Ide T; Uchida K; Kikuta F; Suzuki K; Nakayama H
Vet Pathol; 2010 Jul; 47(4):741-50. PubMed ID: 20418471
[TBL] [Abstract][Full Text] [Related]
9. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytokeratins in gliomas.
Goswami C; Chatterjee U; Sen S; Chatterjee S; Sarkar S
Indian J Pathol Microbiol; 2007 Jul; 50(3):478-81. PubMed ID: 17883112
[TBL] [Abstract][Full Text] [Related]
11. An isomorphic subtype of long-term epilepsy-associated astrocytomas associated with benign prognosis.
Blümcke I; Luyken C; Urbach H; Schramm J; Wiestler OD
Acta Neuropathol; 2004 May; 107(5):381-8. PubMed ID: 15034726
[TBL] [Abstract][Full Text] [Related]
12. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of WT1 in neuroepithelial tumours.
Schittenhelm J; Beschorner R; Simon P; Tabatabai G; Herrmann C; Schlaszus H; Capper D; Weller M; Meyermann R; Mittelbronn M
Neuropathol Appl Neurobiol; 2009 Feb; 35(1):69-81. PubMed ID: 18466223
[TBL] [Abstract][Full Text] [Related]
14. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors.
Herminghaus S; Pilatus U; Möller-Hartmann W; Raab P; Lanfermann H; Schlote W; Zanella FE
NMR Biomed; 2002 Oct; 15(6):385-92. PubMed ID: 12357552
[TBL] [Abstract][Full Text] [Related]
15. Grade classification of neuroepithelial tumors using high-resolution magic-angle spinning proton nuclear magnetic resonance spectroscopy and pattern recognition.
Chen W; Lou H; Zhang H; Nie X; Lan W; Yang Y; Xiang Y; Qi J; Lei H; Tang H; Chen F; Deng F
Sci China Life Sci; 2011 Jul; 54(7):606-16. PubMed ID: 21748584
[TBL] [Abstract][Full Text] [Related]
16. Microtubule-associated protein-2 is a sensitive marker of primary and metastatic neuroblastoma.
Krishnan C; Higgins JP; West RB; Natkunam Y; Heerema-McKenney A; Arber DA
Am J Surg Pathol; 2009 Nov; 33(11):1695-704. PubMed ID: 19701075
[TBL] [Abstract][Full Text] [Related]
17. Expression of PROX1 Is a common feature of high-grade malignant astrocytic gliomas.
Elsir T; Eriksson A; Orrego A; Lindström MS; Nistér M
J Neuropathol Exp Neurol; 2010 Feb; 69(2):129-38. PubMed ID: 20084020
[TBL] [Abstract][Full Text] [Related]
18. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
[TBL] [Abstract][Full Text] [Related]
19. Nestin expression in ganglioglioma.
Duggal N; Hammond RR
Exp Neurol; 2002 Mar; 174(1):89-95. PubMed ID: 11869037
[TBL] [Abstract][Full Text] [Related]
20. Microtubule-associated protein 2 (MAP2)--a promising approach to diagnosis of forensic types of hypoxia-ischemia.
Kühn J; Meissner C; Oehmichen M
Acta Neuropathol; 2005 Dec; 110(6):579-86. PubMed ID: 16328528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
